Rituximab therapy for the type B syndrome of severe insulin resistance.
Coll
Anthony P
AP
Thomas
Stephen
S
Mufti
Ghulam J
GJ
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies / Q000097:blood; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D007074:Immunoglobulin G / Q000097:blood; D007333:Insulin Resistance / Q000276:immunology; D011972:Receptor, Insulin / Q000276:immunology; D000069283:Rituximab; D013577:Syndrome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D006442:Glycated Hemoglobin; D007074:Immunoglobulin G; D011972:Receptor, Insulin; D000069283:Rituximab